Jan Lötvall svensk läkare
Lötvall, Jan
Lötvall, Jan, 1956-....
VIAF ID: 315209843 (Personal)
Permalink: http://viaf.org/viaf/315209843
Preferred Forms
- 100 0 _ ‡a Jan Lötvall ‡c svensk läkare
- 100 1 _ ‡a Lötvall, Jan
-
-
- 100 1 _ ‡a Lötvall, Jan, ‡d 1956-....
-
- 100 1 _ ‡a Lötvall, Jan
-
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Advances in combination therapy for Asthma and COPD, 2011: | |
B cells : from early development to regulating allergic dseases | |
High prevalence of severe asthma in a large random population study | |
Higher risk of wheeze in female than male smokers. Results from the Swedish GA 2 LEN study | |
Human mast cells release extracellular vesicle-associated DNA | |
Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages | |
IgE to Furry Animal Allergen Components Was Associated with Asthma in a Population-Based Study of Adults | |
An IL-2–toxin, DAB389 IL-2, inhibits delayed-type hypersensitivity but enhances IgE antibody production | |
Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. | |
Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses. | |
Immunophenotyping of circulating T helper cells argues for multiple functions and plasticity of T cells in vivo in humans--possible role in asthma | |
Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum | |
Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods | |
In vitro tachyphylaxis to isoprenaline in guinea-pig trachea: influence of theophylline? | |
Increase in pollen sensitization in Swedish adults and protective effect of keeping animals in childhood | |
Increased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA²LEN surveys | |
Indirect airway challenges | |
Induction of nitric oxide synthase in a model of allergic occupational asthma | |
[Inflammation--a cause of asthmatic complaints] | |
Inflammatory responses in skin and airways after allergen challenge in brown Norway rats sensitized to trimellitic anhydride | |
Inhalation therapy of the future--how will it change the way we treat asthma? | |
Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients | |
Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation | |
International consensus on (ICON) pediatric asthma | |
Intranasal fluticasone propionate inhibits allergen induced bone marrow eosinophilia in mice | |
An intranasal glucocorticoid inhibits the increase of specific IgE initiated during birch pollen season | |
Is asthma prevalence still increasing? | |
ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential therapeutic agents to suppress COVID-19 | |
Isolation and characterization of microvesicles from mesenchymal stem cells | |
Large scale questionnaire survey on respiratory health in Sweden: effects of late- and non-response. | |
Leukotriene D4- and prostaglandin F2 alpha-induced airflow obstruction and airway plasma exudation in guinea-pig: role of thromboxane and its receptor | |
Levalbuterol has not been established to have therapeutic advantage over racemic albuterol | |
Local and systemic effects of inhaled AZD9164 compared with tiotropium in patients with COPD. | |
Local proliferation and mobilization of CCR3(+) CD34(+) eosinophil-lineage-committed cells in the lung | |
Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients | |
Lung Regulatory T Cells Express Adiponectin Receptor 1: Modulation by Obesity and Airway Allergic Inflammation | |
Mast cell exosomes promote lung adenocarcinoma cell proliferation - role of KIT-stem cell factor signaling | |
Measurement of airway hyperresponsiveness: new considerations | |
Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage. | |
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. | |
Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10 | |
MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma. | |
Mild experimental exacerbation of asthma induced by individualised low-dose repeated allergen exposure. A double-blind evaluation | |
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines | |
Mitochondrial protein enriched extracellular vesicles discovered in human melanoma tissues can be detected in patient plasma | |
Modulation of allergen-induced bronchoconstriction by fluticasone furoate and vilanterol alone or in combination | |
Motivational foci and asthma medication tactics directed towards a functional day | |
Multi-symptom asthma as an indication of disease severity in epidemiology | |
Multi-symptom asthma is closely related to nasal blockage, rhinorrhea and symptoms of chronic rhinosinusitis-evidence from the West Sweden Asthma Study | |
Murine models of asthma. | |
Network analysis of quantitative proteomics on asthmatic bronchi: effects of inhaled glucocorticoid treatment | |
Neutrophil influx into guinea-pig airway lumen during cholinergic and non-cholinergic bronchoconstriction | |
Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways | |
New topics in bradykinin research. | |
Obituary | |
Onset of action of formoterol versus salmeterol via dry powder inhalers in moderate chronic obstructive pulmonary disease: a randomized, placebo-controlled, double-blind, crossover study | |
Onset of bronchodilation and finger tremor induced by salmeterol and salbutamol in asthmatic patients | |
Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers | |
Oral immunotherapy for peanut allergy: an evidence-based medicine assessment | |
Osteopontin expression and relation to disease severity in human asthma | |
Outer membrane vesicles derived from Escherichia coli up-regulate expression of endothelial cell adhesion molecules in vitro and in vivo | |
Ovalbumin aerosol challenge in actively sensitized guinea pigs: relationship between airway microvascular leakage and airflow obstruction. | |
Past, present and future--beta2-adrenoceptor agonists in asthma management | |
Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD | |
Pediatric brain tumor cells release exosomes with a miRNA repertoire that differs from exosomes secreted by normal cells | |
Peptidase modulation of noncholinergic vagal bronchoconstriction and airway microvascular leakage | |
Personality, adherence, asthma control and health-related quality of life in young adult asthmatics | |
Personality and unachieved treatment goals related to poor adherence to asthma medication in a newly developed adherence questionnaire - a population-based study | |
Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD. | |
Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells | |
Pharmacological similarities and differences between beta2-agonists | |
Plasma exudation into airways induced by inhaled platelet-activating factor: effect of peptidase inhibition | |
Precursor B Cells Increase in the Lung during Airway Allergic Inflammation: A Role for B Cell-Activating Factor | |
Preface | |
Prevalence and risk factors of COPD among never-smokers in two areas of Sweden - Occupational exposure to gas, dust or fumes is an important risk factor. | |
Prevalence, clinical characteristics and morbidity of the Asthma-COPD overlap in a general population sample | |
Prevalence of Chronic Nasal Symptoms in West Sweden: Risk Factors and Relation to Self-Reported Allergic Rhinitis and Lower Respiratory Symptoms | |
Prolonged eosinophil production after allergen exposure in IFN-gammaR KO mice is IL-5 dependent | |
Proteomics in asthma and COPD phenotypes and endotypes for biomarker discovery and improved understanding of disease entities | |
Pulmonary inflammation induced by bacteria-free outer membrane vesicles from Pseudomonas aeruginosa | |
Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment | |
Questionnaire layout and wording influence prevalence and risk estimates of respiratory symptoms in a population cohort | |
Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis | |
Recent educational interventions for improvement of asthma medication adherence | |
Reviewer acknowledgement 2012 | |
A synthetic VIP peptide analogue inhibits neutrophil recruitment in rat airways in vivo | |
β2-mimetyki w leczeniu astmy : przeszłość, teraźniejszość i przyszłość |